Ending the HIV Epidemic With Implementation Science in HRSA's Ryan White HIV/AIDS Program
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Three sites were funded in 2016 as part of Special Projects of National Significance Dissemination of Evidence-Informed Interventions initiative to implement an evidence-informed intervention designed to link people with HIV in jail to community HIV care using a transitional care coordinator. Presenters will discuss the barriers and facilitators related to linking to care and achieving and maintaining viral suppression post-release.
Resource (Conference Presentation) updated 09/14/2023
Living with substance use disorder can compromise prevention interventions, diagnosis of HIV, engagement and retention in care, and viral suppression. Clinical coordinators serve an essential, unduplicated role in the provision of medication-assisted therapy (MAT) in HIV primary care. This presentation will share lessons learned to support the replication of MAT programs, including the clinical coordinator role, within your setting.
Resource (Conference Presentation) updated 09/14/2023
Prior analyses among transgender women receiving Ryan White Part A services in New York City have found evidence of disparities in HIV outcomes. This presentation will focus on viral suppression and the New York Eligible Metropolitan Area’s efforts to address care continuum outcome disparities affecting clients of transgender experience.
Resource (Conference Presentation) updated 09/14/2023
An overview will be provided on the prevention of opioid use disorders in Ryan White clinics and AIDS service organizations. Information will be provided on how to launch the Take Back, Educate, and Inundate initiative to encourage the launch of innovative approaches to reducing opioid use and misuse with people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Using an innovative Stakeholder Real-Time Delphi approach, 805 stakeholders (e.g., people with HIV, HIV service organization staff, HIV planning council representatives) from across the United States interactively assessed the prevalence rate and individual-level negative impacts of five substance abuse disorders (SUDs), which were combined to estimate the population-level negative impact of each SUD.
Resource (Conference Presentation) updated 09/14/2023
This peer-led workshop will include skill-building interactive sessions about two evidence-informed interventions that address opioid use disorders among people with HIV, Buprenorphine Treatment and Screening, Brief Intervention, and Referral to Treatment.
Resource (Conference Presentation) updated 09/14/2023
Substance abuse, interpersonal violence, depression, and HIV are part of overlapping and intersecting epidemics which adversely affect the prognosis and intensify the burden of each. This session will review existing literature on this syndemic, lessons learned in initial implementation of a screening and linkage program, and implications for practice.
Resource (Conference Presentation) updated 09/14/2023
This presentation will review how the Michigan Department of Health and Human Services Chronic Disease Division collaborated with the HIV/STI division and local AIDS service organizations to develop innovative, client-centered tobacco dependence treatment programs to address the high tobacco use rates among people with HIV.
Resource (Conference Presentation) updated 09/14/2023
This session will use stories to describe a small 'village,' a model to assist in, prevent relapse of, and remove barriers to care for patients with opioid use disorders. The use of buprenorphine and a patient-centered interactive phone application have added an additional layer of success in patient recovery.
Resource (Conference Presentation) updated 09/14/2023
Among people with HIV who also inject drugs, an estimated 80 to 90 percent are coinfected with Hepatitis C (HCV.) This panel will provide updates on screening and referral activities and demonstrate how community and city partners are overcoming barriers to HCV care among PWID.
Resource (Conference Presentation) updated 09/14/2023
Transgender women, especially those of color, have substantially lower rates of viral suppression than people with HIV in general. The New York City HIV Planning Council collaborated with the community to develop guiding recommendations that drove the development of the jurisdiction's first psycho-social service directive specifically for people of transgender, intersex, non-binary, and/or non-conforming experience.
Resource (Conference Presentation) updated 09/14/2023
This workshop will explore the implementation of peer-led, evidence-informed interventions for transgender women with HIV. The programs are Healthy Divas, and Transgender Women Engagement and Entry to Care Project (T.W.E.E.T.). Attendees will learn the core elements of these interventions and how they improve engagement in care, treatment adherence, and viral suppression in Alabama and Michigan.
Resource (Conference Presentation) updated 09/14/2023